Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay.
Sanath Kumar JanakaNatasha M ClarkDavid T EvansHuihui MouMichael FarzanJoseph P ConnorPublished in: PloS one (2021)
Our observations support the use of an anti-RBD assay such as the Lumit Dx assay, as an optimal predictor of the neutralization capability of CCP.